Vitrolife AB
STO:VITR
Vitrolife AB
STO:VITR
Price:
181.1 SEK
-1.36%
Market Closed
Updated:
Jun 9, 2024
Vitrolife AB
Research & Development
|
Vitrolife AB
Research & Development Peer Comparison
Comparables:
BIOG B
HNSA
BONEX
SOBI
BIOA B
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vitrolife AB
STO:VITR
|
Research & Development
-kr124m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-8%
|
|
|
Biogaia AB
STO:BIOG B
|
Research & Development
-kr104.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Hansa Biopharma AB
STO:HNSA
|
Research & Development
-kr419.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Research & Development
-kr58.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Research & Development
-kr3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-20%
|
|
|
BioArctic AB
STO:BIOA B
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vitrolife AB's Research & Development?
Research & Development
-124m
SEK
-124m
SEK
Based on the financial report for Mar 31, 2024, Vitrolife AB's Research & Development amounts to -124m SEK.
What is Vitrolife AB's Research & Development growth rate?
Research & Development CAGR 10Y
-8%
-8%
Over the last year, the Research & Development growth was 7%.
You don't have any saved screeners yet
